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Abstract
The regulation of alternative splicing involves interactions between RNA-binding proteins and pre-mRNA positions close to
the splice sites. T-cell intracellular antigen 1 (TIA1) and TIA1-like 1 (TIAL1) locally enhance exon inclusion by recruiting U1
snRNP to 59 splice sites. However, effects of TIA proteins on splicing of distal exons have not yet been explored. We used
UV-crosslinking and immunoprecipitation (iCLIP) to find that TIA1 and TIAL1 bind at the same positions on human RNAs.
Binding downstream of 59 splice sites was used to predict the effects of TIA proteins in enhancing inclusion of proximal
exons and silencing inclusion of distal exons. The predictions were validated in an unbiased manner using splice-junction
microarrays, RT-PCR, and minigene constructs, which showed that TIA proteins maintain splicing fidelity and regulate
alternative splicing by binding exclusively downstream of 59 splice sites. Surprisingly, TIA binding at 59 splice sites silenced
distal cassette and variable-length exons without binding in proximity to the regulated alternative 39 splice sites. Using
transcriptome-wide high-resolution mapping of TIA-RNA interactions we evaluated the distal splicing effects of TIA proteins.
These data are consistent with a model where TIA proteins shorten the time available for definition of an alternative exon by
enhancing recognition of the preceding 59 splice site. Thus, our findings indicate that changes in splicing kinetics could
mediate the distal regulation of alternative splicing.
Citation: Wang Z, Kayikci M, Briese M, Zarnack K, Luscombe NM, et al. (2010) iCLIP Predicts the Dual Splicing Effects of TIA-RNA Interactions. PLoS Biol 8(10):
e1000530. doi:10.1371/journal.pbio.1000530
Academic Editor: Tom Misteli, National Cancer Institute, United States of America
Received April 7, 2010; Accepted September 15, 2010; Published October 26, 2010
Copyright: ! 2010 Wang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Medical Research Council (MRC, www.mrc.ac.uk), European Research Council (ERC, erc.europa.eu, 206726-CLIP), Human
Frontier Science Program (HFSP, www.hfsp.org, RGP0024/2008-C), and Slovenian Research Agency (P2-0209, J2-2197, L2-1112, Z7-3665). The funders had no role
in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Abbreviations: 39 UTR, 39 untranslated region; ARE, AU-rich element; iCLAP, individual-nucleotide resolution UV-crosslinking and affinity purification; iCLIP,
individual-nucleotide resolution UV-crosslinking and immunoprecipitation; KD, knockdown; ncRNA, non-coding RNA; nt, nucleotide; RRMs, RNA recognition
motifs; snRNP, small nuclear ribonucleoprotein particles; TIA1, T-cell intracellular antigen 1; TIAL1, TIA1-like 1 or TIA1-related
* E-mail: jule@mrc-lmb.cam.ac.uk
. These authors contributed equally to this work.
Introduction
Pre-mRNA splicing is catalysed by small nuclear ribonucleo-
protein particles (snRNP) that recognise the splice sites on pre-
mRNA and remove the introns with great precision. U1 and U2
snRNPs recognise the core motifs present at the 59 and 39 splice
sites, respectively [1]. These core splice site motifs, however,
contain only about half of the information required to define
exon/intron boundaries [2]. Additional sequence elements can
recruit regulatory RNA-binding proteins either to enhance or
silence splice site recognition depending on their position relative
to the splice sites [3,4].
T-cells intracellular antigen 1 (TIA1) and TIA1-like1 (TIAL1,
also known as TIAR) are closely related RNA-binding proteins.
They have three RNA recognition motifs (RRMs) and a carboxyl-
terminal glutamine-rich region [5,6]. RRM2 is the major domain
binding to uridine-rich sequences, RRM3 is thought to bind to
RNA with no specificity, and RRM1 has no detectable RNA
binding affinity in vitro [7]. Instead, RRM1 and the C-terminus
interact with U1 snRNP to enhance its recruitment to the 59 splice
site of alternative exons [8–11].
TIA1 and TIAL1 are involved in multiple aspects of RNA
metabolism. They are present in both the cytoplasm and the
nucleus and shuttle between these two compartments in a manner
that requires the RRM2 and RRM3 domains [12,13]. In the
nucleus, TIA1 and TIAL1 regulate alternative splicing by binding
to U-rich sequences adjacent to the 59 splice site and recruiting
U1-C to promote exon inclusion [8,10,11,14,15]. They also
regulate the splicing of their own mRNAs, and the resulting two
major isoforms have different splicing activity [16,17]. In the
cytoplasm, TIA1 and TIAL1 function as translational silencers by
binding to the 39 untranslated region (39 UTR) of mRNAs [18,19].
They were also implicated in stress-induced translational silencing
in stress granules [12,20]. In addition, TIA1 and TIAL1 were
shown to promote apoptosis [21], and depletion of both proteins
promotes cell proliferation [22].
The role of cis-regulatory RNA motifs located close to
alternative exons has been widely investigated, but recent studies
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suggest that distal regulatory motifs might also play an important
role [4,23,24]. For instance, Nova1 and Nova2 proteins can
silence inclusion of an alternative exon when binding downstream
of the preceding exon [4,24]. In contrast, Nova proteins enhance
inclusion when binding directly downstream of an alternative exon
[4,24]. This suggested that the local and distal effects of Nova
binding downstream of a 59 splice site are reciprocal [25]. Since
the function of TIA proteins in recruiting U1 snRNP to 59 splice
site is well characterised, these proteins offered a unique
opportunity for a comprehensive study of the distal splicing effects
of changes in 59 splice site recognition.
Ultraviolet (UV)-crosslinking and immunoprecipitation (CLIP)
was first developed to identify RNA sites bound by the splicing
regulators Nova1 and Nova2 in brain tissue [26]. The traditional
CLIP cDNA library preparation protocol suffers from a potential
loss of cDNAs due to truncation immediately before the ‘‘crosslink
site,’’ where at least one amino acid remains covalently attached
after proteinase K digestion [27]. Therefore, we used a modified
cDNA library preparation protocol that was recently developed
(iCLIP), which identifies truncated cDNAs by introducing the
second adapter to cDNAs after reverse transcription [28]. In
addition, iCLIP introduces a random DNA sequence (barcode) to
cDNAs during reverse transcription to differentiate between
unique cDNA products and PCR duplicates. Since the first
nucleotide of resulting cDNA sequences most likely locates directly
downstream of the crosslink site, iCLIP enables quantitative and
high resolution analysis of protein crosslinking to the target RNAs
[28].
Here, we used iCLIP to identify the RNA crosslink sites of TIA
proteins. iCLIP showed a high density of TIA crosslinking in 39
UTRs of mRNAs and in non-coding RNAs (ncRNAs). Intronic
TIA binding clusters were restricted to positions immediately
downstream of 59 splice sites. TIA binding at the 59 splice site of an
alternative exon and/or the preceding exon predicted its dual
splicing effects. TIA binding enhanced inclusion of proximal
upstream alternative exons and usage of upstream alternative
splice sites but silenced distal downstream alternative exons if these
lacked direct TIA binding. Interestingly, TIA proteins also
regulated distal alternative 39 splice sites, suggesting that by
enhancing 59 splice site recognition, they can indirectly silence
downstream alternative exons.
Results
iCLIP and iCLAP Identify Crosslink Sites of TIA1 or TIAL1
iCLIP was used to identify the crosslink sites of TIA1 and
TIAL1 in HeLa cells in a transcriptome-wide manner. Briefly,
cells were UV-irradiated, lysed, and RNA was digested with
RNase I to a size of approximately 40–100 nucleotides (nt). The
proteins were immunoprecipitated using TIA1 or TIAL1-specific
antibodies, and the protein-RNA complexes were subjected to 59
labelling using 32P-c-ATP for visualisation after SDS-PAGE
separation. The specificity of each antibody was determined by
overexpression of TIA1 or TIAL1 in HeLa cells (Figures 1A, 1B,
S1A and S1B). TIA1 and TIAL1 antibodies each detected RNA-
protein complexes of correct size only from UV-crosslinked cells
and only if an antibody was used for immunoprecipitation.
Furthermore, the signal decreased in TIA1/TIAL1 double
knockdown (KD) cells and increased when the corresponding
protein was overexpressed (Figure 1A and 1B). There was a slight
cross-reactivity of the TIA1 antibody to the TIAL1 protein
(Figures 1A and S1A, when TIAL1 was overexpressed). However,
during immunoprecipitation, the TIA1 antibody mainly recog-
nised the TIA1 protein, as no increase was seen when TIAL1 was
overexpressed (Figure S1B).
To assess the RNA sequence specificity of TIA1 or TIAL1
without the use of antibodies, we also developed crosslinking and
affinity purification (iCLAP), a method to purify Strep/His
double-tagged TIA1 and TIAL1 proteins using stringent affinity
purification. This method circumvents any cross-reactivity of
antibody that would identify the same crosslink sites for both
proteins. TIA1 and TIAL1 with the Strep/His tag on the N- or C-
terminus were overexpressed in HeLa cells. After UV crosslinking
and RNase I digestion, the protein-RNA complexes were first
purified with magnetic streptavidin bead before ligation to the 39
RNA adaptor. Cobalt beads were then used to further purify the
protein-RNA complexes under denaturing conditions (8 M urea,
Figure S1E). iCLAP detected protein-RNA complexes only if cells
were transfected with an appropriate construct, and no signal was
detected in vector-transfected or non-crosslinked cells (Figure
S1F). In summary, the analysis of radioactive protein-RNA
complexes indicated that both iCLIP and iCLAP isolated specific
protein-RNA complexes without contamination from other co-
purified proteins or RNAs.
To amplify the co-purified RNAs, these were dephosphorylated
and ligated to the 39 RNA adaptor on beads during immunopre-
cipitation (iCLIP) or affinity purification (iCLAP). After SDS-
PAGE and nitrocellulose transfer, the protein-RNA complexes of
70–150 kDa were excised from the membrane (Figure S1C) and
subjected to proteinase K digestion. The RNA was reverse
transcribed with a primer complementary to the 39 RNA adaptor,
which contained a second half complementary to the 59 Solexa
sequencing primer separated by a BamHI digestion site. The
cDNA was then self-circularised, digested with BamHI, giving a
product with corresponding adaptors at both ends, and amplified
by PCR (Figure S1D). PCR products were sequenced using single-
end 44 nt reads on the Illumina GA2 system.
Three independent replicate iCLIP experiments and one
iCLAP experiment were performed for both TIA1 and TIAL1
(Table S1). In total, 18.4 million iCLIP sequences were generated,
74% of which aligned to the human genome by allowing only
single genomic hits and one nucleotide mismatch (Table S2).
Unique cDNAs were identified based on random barcodes, and
the crosslink site was mapped to the first nucleotide preceding the
start of the cDNAs (Figure 1C). Together, iCLIP produced
869,782 unique cDNA reads for TIA1 and 2,966,801 unique
Author Summary
Studies of splicing regulation have generally focused on
RNA elements located close to alternative exons. Recently,
it has been suggested that splicing of alternative exons
can also be regulated by distal regulatory sites, but the
underlying mechanism is not clear. The TIA proteins are
key splicing regulators that enhance the recognition of 59
splice sites, and their distal effects have remained
unexplored so far. Here, we use a new method to map
the positions of TIA-RNA interactions with high resolution
on a transcriptome-wide scale. The identified binding
positions successfully predict the local enhancing and
distal silencing effects of TIA proteins. In particular, we
show that TIA proteins can regulate distal alternative 39
splice sites by binding at the 59 splice site of the preceding
exon. This result suggests that alternative splicing is
affected by the timing of alternative exon definition
relative to the recognition of the preceding 59 splice site.
These findings highlight the importance of analysing distal
regulatory sites in order to fully understand the regulation
of alternative splicing.
iCLIP Predicts the Dual TIA Splicing Effects
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Figure 1. iCLIP identifies the TIA1 and TIAL1 crosslink sites with nucleotide resolution. Autoradiogram of 32P-labelled RNA crosslinked to
TIA1 (A) or TIAL1 (B) in HeLa cells. Immunoprecipitation was performed with either anti-TIA1 or anti-TIAL1 antibody using lysate from UV-crosslinked
HeLa cells, cells transfected with TIA1 or TIAL1, TIA1/TIAL1 KD cells, or non-crosslinked cells. High and low RNase concentrations were used and
protein G beads were used as a control. The Western blots below the autoradiograms show the input lysate used for each immunoprecipitation. (C)
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cDNA reads for TIAL1 (Table S2). The iCLIP no-antibody
controls, performed in parallel with two of the iCLIP experiments,
did not generate detectable PCR products. When submitted for
sequencing, they generated 1,074 and 7,798 unique cDNAs
mapping to the human genome (Table S2). Since TIA1 or TIAL1
iCLIP generated 100-fold more cDNAs than controls, we
estimated that over 99% of cDNAs from the iCLIP experiment
represent RNA sites specifically crosslinked to TIA1 or TIAL1.
TIA1 and TIAL1 Bind the Same RNA Sites
The random barcode introduced into iCLIP cDNAs allowed us
to analyse the distribution of TIA1 and TIAL1 on human RNAs
in a quantitative and reproducible manner (Figure S2). Only 1.7%
of cDNAs mapped in antisense orientation to annotated genes,
confirming the high strand specificity of iCLIP. Only 10% of
cDNAs mapped to intergenic regions (Figure 2A). The highest
cDNA density was seen in 39 UTRs and ncRNAs, which together
contained 22% of all cDNAs (Figure 2A and 2B). 2,277 ncRNAs
and 8,602 39 UTRs had a higher cDNA density than the whole-
genome average, and the cDNA enrichment correlated between
TIA1 and TIAL1 iCLIP (Pearson correlation coefficient r=0.95
and r=0.90, respectively; Figure S3G and S3H). The ncRNA and
39 UTR sites with the highest cDNA counts mapped to highly
expressed RNAs such as tRNAs and histone mRNAs (Figure S4B).
Interestingly, cDNA enrichment in 39 UTRs was 5-fold higher
than in the coding sequence (Figure 2B), in agreement with past
findings that TIA proteins bind 39 UTR to regulate translation
[18,29–31].
Fifty-eight percent of TIA1 and 60% of TIAL1 cDNAs mapped
to introns (Figure 2A). 67,002 introns had a cDNA density higher
than the whole-genome average, and the cDNA enrichment
correlated between TIA1 and TIAL1 iCLIP (r=0.81; Figure S3I).
The cDNA density in introns was on average 18-fold lower than in
39 UTRs and ncRNAs (Figures 2B and S3I). Past studies have
shown that TIA1 and TIAL1 regulate alternative splicing of exon
6 of FAS mRNA [14,17,32,33]. Both TIA1 and TIAL1
crosslinked to previously characterised intronic binding sites in
FAS pre-mRNA (Figure S5A).
Past studies suggested that TIA1 and TIAL1 have different
RNA binding specificities [7,34]. However, the two proteins can
regulate alternative splicing of the same exons [17]. We therefore
analysed the in vivo RNA specificity of the two proteins using our
iCLIP data. As a control, the iCLIP positions were randomised
within the co-expressed genomic regions. The 21 nt sequence
surrounding the crosslink sites was compared to randomised
positions to identify the pentamers enriched at the TIA1 and
TIAL1 crosslink sites. Pentamer enrichment in TIA1 and TIAL1
iCLIP data was highly correlated, and UUUUA and AUUUU
were the two most common pentamers (r=0.99; Figures 2C and
S3A, Table S3). Comparing replicate iCLIP experiments of either
protein verified the high reproducibility of the observed sequence
specificity (Figure S3C and S3D). Similarly, iCLAP experiments
with both proteins were also highly correlated and were enriched
for the same pentamers as iCLIP, independently supporting the
determined sequence specificity of both proteins (Figure S3B).
These results demonstrated that TIA1 and TIAL1 share the same
in vivo RNA binding specificity.
Due to the high stringency of purification of protein-RNA
complexes, iCLIP purified RNA sites that directly interact with
TIA proteins. However, it is possible that some of these sites
represent transient and low-affinity TIA-RNA interactions. To
specifically analyse the high-affinity RNA binding sites, we
determined clusters of TIA1 or TIAL1 crosslink sites with a
maximum spacing of 15 nt containing a significant cDNA count
when compared to randomised positions (FDR ,0.05). This
identified 12,048 TIA1 and 34,058 TIAL1 crosslink clusters.
Uridine represented 82% of TIA1 and 75% of TIAL1 clustered
crosslink sites (i.e., crosslink sites that located within these clusters)
and was also the most common nucleotide at all positions up to
10 nt away from these crosslink sites (Figure S3E). This agreed
with the past studies showing that TIA proteins bind to uridine-
rich motifs [8,14,17,19].
To compare the overlap between binding of TIA1 and TIAL1
to the same sites, we analysed the proportion of crosslink clusters
identified by both proteins. Eighty-three percent (10,021 / 12,048)
of TIA1 crosslink clusters overlapped with a TIAL1 crosslink site,
and 59% (20,047 / 34,058) of TIAL1 crosslink clusters overlapped
with a TIA1 crosslink site. The overlap depended on the number
of cDNAs that defined a cluster. Ninety-nine percent of the
crosslink clusters that were defined by five or more TIA1 cDNAs
overlapped with a TIAL1 crosslink site (Figure 2D). We also
assessed the distances between clustered TIA1 and TIAL1
crosslink sites. TIAL1 crosslink sites overlapped with TIA1
crosslink sites 15-fold more common than with randomised
TIA1 iCLIP positions (Figure S3F). These analyses indicated that
the binding sites of TIA1 and TIAL1 largely overlap.
Since both proteins showed a redundant binding behaviour, the
iCLIP data of TIA1 and TIAL1 were merged to increase the
reliability of cluster definition, which depends on the number of
unique cDNA sequences. 46,970 crosslink clusters were identified
in the joint TIA1/TIAL1 data with a maximum spacing of 15 nt
(FDR,0.05). The cDNA counts within these crosslink clusters
were highly correlated between TIA1 and TIAL1 data, indicating
that they had similar affinity to their common RNA binding sites
(r=0.85; Figure 2E). Furthermore, the cDNA counts were
correlated even at the single-nucleotide level, as evident in the 39
UTR of MYC mRNA, which is a functionally validated
translational target of the TIA proteins (r=0.73; Figures 2F and
S5B) [30,35]. Taken together, iCLIP data suggested that TIA1
and TIAL1 have similar affinity for their common RNA binding
sites.
iCLIP Predicts TIA Effects on Splicing of Cassette Exons
In order to identify the candidate positions where TIA proteins
bind to regulate splicing, we compared the distribution of TIA1/
TIAL1 iCLIP clustered crosslink sites close to constitutive and
alternative cassette exons (Figure 3A). Thirty-fold enrichment was
seen at positions 10–28 nt downstream of exon/intron boundaries
compared to the last 20 nt of both type of exons. Surprisingly, the
constitutive and alternative exons showed a similar extent of
crosslinking in this region. Approximately 5% of both types of
exons contained a TIA crosslink cluster in this region.
Since TIA proteins were previously described as splicing
enhancers [8,14], we hypothesised that TIA crosslink clusters
TIA1 and TIAL1 crosslink to uridine tracts downstream of the alternative 59 splice sites in the CLIP4 gene. The cDNA positions are colour-coded for
three replicate TIA1 and TIAL1 experiments, and the random barcode (shown on the left) is used to identify unique iCLIP cDNAs (number in brackets
indicates the number of corresponding PCR duplicates). Below, the bar graphs show the cDNA count (number of cDNAs at each crosslink site). Pre-
mRNA sequence is shown below with crosslink nucleotides in red. The exon and intron positions of the two isoforms of CLIP4 mRNA are shown at the
bottom.
doi:10.1371/journal.pbio.1000530.g001
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could be used to predict proximal enhanced exons (Figure 3B).
Therefore, a regulatory logic was defined where TIA crosslink
clusters 10–28 nt downstream of an alternative exon (region a in
Figure 3B) predicted enhanced exon inclusion. This predicted
1,620 alternative cassette exons as enhanced by TIA proteins.
Furthermore, since binding of Nova proteins downstream of the
preceding exon could silence distal alternative exons [4], we
defined a second regulatory logic for distal silencing. TIA crosslink
clusters 10–28 nt downstream of the preceding exon (region b in
Figure 3B) predicted silenced alternative exon inclusion if TIA
crosslink clusters were absent in the region a. This predicted 1,962
alternative cassette exons as silenced by TIA proteins.
To assess the iCLIP predictions in an unbiased way, the splicing
changes in TIA1/TIAL1 KD HeLa cells were analysed using a
high-resolution splice-junction microarray. Microarray data were
analysed with the ASPIRE 3 software [28]. The microarray
detected splicing changes in 1,213 cassette exons (|DIrank|$1),
46 of which were further assessed using reverse transcription and
0
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Figure 2. TIA1 and TIAL1 crosslink to the same positions in human RNAs. (A) The percentage of cDNAs from TIA1 and TIAL1 iCLIP that
mapped to different types of RNAs. (B) The fold enrichment of average cDNA density from TIA1 and TIAL1 iCLIP in different types of RNAs relative to
the average cDNA density in the whole genome. (C) Pentamer z scores at the 21 nt sequence surrounding crosslink sites (210 nt to +10 nt) are
shown for TIA1 and TIAL1 iCLIP. The sequences of the two most enriched pentamers and the Pearson correlation coefficient (r) between the TIA1 and
TIAL1 z scores are shown. (D) Reproducibility of TIA1 and TIAL1 crosslink clusters. Percentage of crosslink clusters with a given cDNA count in TIA1
iCLIP that were also identified in TIAL1 iCLIP is shown. (E) Contour plot comparing TIA1 and TIAL1 cDNA counts in the 46,970 crosslink clusters. The
darkness of contours increases with the number of clusters. The Pearson correlation coefficient (r) between the TIA1 and TIAL1 cDNA counts in the
clusters is shown. (F) Crosslink sites of TIA1 and TIAL1 in the 39 UTR of the MYC gene. The bar graph shows the number of cDNAs that identified each
crosslink site. The Pearson correlation coefficient (r) between the TIA1 and TIAL1 cDNA counts at individual nucleotides is shown.
doi:10.1371/journal.pbio.1000530.g002
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PCR (RT-PCR) and capillary electrophoresis (Text S1). RNA was
isolated from cells treated with three different siRNA oligonucle-
otide pairs targeting TIA1 and TIAL1, and with control siRNA
oligonucleotides (for knockdown efficiency, see Figure S6). Primer
pairs generated a PCR product for 40 of the 46 tested splicing
events, with 30 detecting two or more splicing isoforms. Among
these, RT-PCR validated 86.7% (26/30) of the splicing changes,
confirming the high accuracy of the microarray data (Figure S9A,
Table S4).
We assessed the accuracy of iCLIP predictions by comparing
them to the splicing changes identified by the microarray. Exons
were divided into subsets according to the confidence of the
detected splicing change (DIrank), and the number of exons
correctly predicted by iCLIP was identified in each subset. iCLIP
predicted approximately 5% of false positives in control exons
(|DIrank|,0.1; Figure 3C). However, iCLIP predicted a
significantly higher number of exons among those with a
detectable splicing change (p,0.05, Fisher’s Exact Test;
Figure 3C). For these exons, iCLIP correctly predicted the
direction of splicing change for 105 of 123 exons (85%), out of
which 87 were enhanced (DIrank $2) and 18 were silenced
(DIrank #22). For example, a TIA crosslink cluster downstream
of exon 23a in NF1 pre-mRNA located to a previously described
functional TIA binding site [36], and it correctly predicted the
enhancing effect of the TIA proteins (Figure 3D). In contrast, a
TIA crosslink cluster downstream of the exon preceding the
alternative exon in LRRFIP2 pre-mRNA correctly indicated the
TIA-dependent silencing (Figure 3E).
To assess whether TIA proteins bind at additional positions to
regulate splicing, we comprehensively analysed the positions of
TIA crosslinking in target RNAs with respect to the observed
splicing changes (Figure 4A). Each clustered crosslink site in an
individual RNA was considered as one crosslink event. The RNA
map showed an increase in the number of crosslink events
downstream of the exons, confirming that the predictive code
included the primary positions where TIA proteins regulate
splicing. There was a decrease in the number of crosslink events
downstream of the silenced exons, combined with a significant
increase downstream the preceding exon (Figure 4A). Similarly,
mutually exclusive exons such as in FYN pre-mRNA displayed
TIA crosslinking downstream of the enhanced exon but not in the
vicinity of the silenced exon (Figure S8A). Since silenced exons had
a reduced proximal TIA binding compared to control exons, TIA
binding at the preceding exon was the most likely cause for the
silencing effect.
The RNA map demonstrated a significant increase in the
number of crosslink events downstream of the enhanced exons. To
further validate the function of TIA binding at this position, we
constructed a reporter minigene containing the alternative exon 5
and the flanking introns and exons of OGT pre-mRNA
(Figure 4B). In the iCLIP data, the only TIA crosslink cluster
present in this region was located downstream of the 59 splice site.
Overexpression of either TIA1 or TIAL1 in HeLa cells increased
exon inclusion, whereas TIA KD HeLa cells decreased exon
inclusion (Figure 4B). Overexpression of either TIA1 or TIAL1 in
the KD cells was able to restore exon inclusion. This confirmed
that both TIA1 and TIAL1 could enhance inclusion of the exon.
To directly test whether the RNA sequence underlying the TIA
crosslink cluster is necessary for the ability of TIA proteins to
enhance exon inclusion, the 40 nt of intronic sequence down-
stream of the exon were replaced with a sequence from CDC25C
pre-mRNA, which did not contain any TIA crosslink sites
(Figure 4B). Splicing of the mutant minigene did not change in
response to the increased or decreased TIA protein levels
(Figure 4B). Thus, the TIA crosslink clusters located downstream
of enhanced exons identified the RNA sites necessary to mediate
the enhancing effect of TIA proteins.
TIA Proteins Maintain Splicing Fidelity at the 59 Splice Site
Extensive TIA crosslinking downstream of constitutive exons
suggested that in addition to regulating alternative splicing, TIA
proteins might also play a role in maintaining splicing fidelity.
Microarray analysis detected increased retention of 143 introns
and decreased retention of 102 introns in TIA KD cells. We tested
18 of these introns using real-time PCR with a 94% validation rate
(Figure S7B, Table S5). An example of an intron retained in KD
cells is shown in PIAA2 pre-mRNA, which contains TIA crosslink
sites downstream of the 59 splice site (Figure S7A). The introns that
were inefficiently spliced in KD cells had a significantly increased
number of crosslink events downstream of the 59 splice sites
compared to control introns, indicating that TIA1 negatively
regulates intron retention (Figure 4C). This is consistent with a
past study using the msl-2 reporter minigene, which showed that
TIA1 binding to the uridine-rich track prevents intron retention
[37]. Our results indicate that maintaining splicing fidelity at 59
splice sites of constitutive exons is a widespread function of TIA
proteins.
iCLIP Predicts TIA Effects on Usage of Alternative 59
Splice Sites
In addition to regulating splicing of cassette exons, TIA
proteins can also regulate the usage of alternative 59 splice sites
[38]. We therefore hypothesised that TIA crosslink clusters could
be used to predict regulation of variable-length exons (Figure 5A).
Since the variable regions are often very short, precise
identification of binding sites is crucial. To test whether the
resolution of iCLIP was sufficient to resolve dual regulation of
Figure 3. iCLIP predicts the regulation of alternative cassette exons. (A) The nucleotide-resolution RNA map of TIA1/TIAL1 iCLIP crosslink
clusters at 59 splice sites of constitutive (grey line) and alternative (black bars) exons. Percentage of exons containing crosslink sites in 20 nt of exonic
and 80 nt of intronic sequence is shown. The region ‘‘x’’ 10–28 nt downstream of exon/intron boundaries contains 30-fold enrichment of crosslink
events if compared by the last 20 nucleotides of exonic sequence. (B) Logic functions of the TIA iCLIP code that predict splicing regulation. a and b
are regions 10–28 nt downstream of exon/intron boundaries that predict enhanced or silenced exons. (C) The exons analysed by the splice-junction
microarray are divided into intervals relative to their splicing change, and percentage of exons predicted by iCLIP in each interval is shown. The stars
mark those categories where predictions perform significantly better than on control exons (* p,0.05, Fisher’s Exact Test). (D,E) iCLIP crosslink sites
surrounding the enhanced exon 23a in NF1 pre-mRNA (D) and the silenced exon in LRRFIP2 pre-mRNA (E). The cDNA counts for TIA1 and TIAL1 are
shown in bar graphs (blue bars represent crosslinking to the sense strand, and orange bars to the antisense strand of the genome), and the crosslink
(XL) clusters (FDR,0.05) are marked with grey rectangles. The arrow above the bar graphs shows the previously identified TIA binding sites. RNA
from KD cells prepared with three different siRNA oligonucleotides and their quantification was analysed by RT-PCR and capillary electrophoresis.
Capillary electrophoresis image and signal quantification are shown below the bar graphs. Quantified transcripts including (in) or excluding (ex) the
regulated alternative exon are marked on the right. Average quantification values of exon inclusion (white) and exclusion (grey) are given as a
fraction of summed values. Error bars represent standard deviation of three replicates and p values are also calculated (* p,0.05, *** p,0.001, one-
way ANOVA).
doi:10.1371/journal.pbio.1000530.g003
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Figure 4. RNA maps of TIA-regulated cassette exons and introns. RNA map showing the percentage of alternative cassette exons (A) or
retained introns (C) with clustered TIA1/TIAL1 crosslink sites at exon/intron boundaries, including 20 nt of exonic and 60 nt of intronic sequence. The
number of crosslink events at each region ‘‘x’’ 10–28 nt downstream of exon/intron boundaries and the total number of exons analysed are shown
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Test). (B) Minigene validation of enhanced alternative cassette exon from OGT1 pre-mRNA. The schematic diagram of each isoforms is shown, and the
TIA binding sites are zoomed in above, with crosslinking nucleotides in red. The mutated sequences are shown below. Capillary electrophoresis
image and signal quantification are shown below. Quantified transcripts including (in) or excluding (ex) the regulated alternative exon are marked on
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alternative 59 splice sites, a regulatory logic was defined where
TIA crosslink clusters 10–28 nt downstream of the intron-distal
59 splice site (position a in Figure 5A) predicted silenced variable
exons (i.e., increased usage of the intron-distal 59 splice site).
Conversely, TIA crosslink clusters 10–28 nt downstream of the
intron-proximal 59 splice site (position b in Figure 5A) predicted
enhanced variable exons if TIA crosslink clusters were absent
downstream of the intron-distal site. This logic predicted TIA-
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Figure 5. iCLIP predicts the regulation of alternative 59 splice sites. (A) Logic functions of the TIA iCLIP code that predict splicing regulation.
a and b are regions 10–28 nt downstream of exon/intron boundaries that predict enhanced or silenced exons. (B) The percentage of exons predicted
by iCLIP is compared to the splicing change detected by microarray (* p,0.05, Fisher’s Exact Test). (C) Diagrams showing a section of variable 59
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doi:10.1371/journal.pbio.1000530.g005
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dependent silencing and enhancing for 84 and 172 variable-
length exons, respectively.
The microarray detected a splicing change in 213 variable-
length exons in KD cells (|DIrank|$1), 147 of which were a result
of alternative 59 splice site use. The accuracy of microarray data
was assessed by analysis of seven alternative 59 splice sites with a
100% validation rate (Figures 5D, 5E, and S9B; Table S4). iCLIP
predicted approximately 3% of false positives in either direction
among the control exons (|DIrank|,0.1; Figure 5B). However,
iCLIP predicted a significantly higher number of true positives
among the exons that had splicing change in KD cells (p,0.05,
Fisher’s Exact Test; Figure 5B). Among these exons, iCLIP
correctly predicted 18 out of 19 exons (95%), of which 8 were
enhanced exons (DIrank $2) and 10 were silenced (DIrank #22).
For example, a crosslink cluster downstream of the intron-distal
alternative 59 splice site was associated with silencing of the
variable portion of exon 11 in CLIP4 pre-mRNA (Figure 5D). In
contrast, a crosslink cluster downstream of the intron-proximal
alternative 59 splice site was associated with enhanced inclusion of
the variable portion of exon 33 in CHD9 pre-mRNA (Figure 5E).
To further assess the predictive value of iCLIP independently of
the microarray, the nine alternative 59 splice sites with the highest
iCLIP cDNA counts at predictive positions were analysed by RT-
PCR. RT-PCR detected alternative isoforms for five of these
exons, and all of these showed a splicing change in KD cells
(Figure S9D). iCLIP correctly predicted the direction of splicing
change for all of these exons (Figures 5C). Furthermore, we
comprehensively analysed the positions of TIA crosslink events in
target RNAs with respect to the observed splicing change
(Figure 6A). In agreement with the predictive regulatory logic,
there was a significant increase in the number of crosslink events
downstream of the enhanced 59 splice sites, but not at any other
positions in the RNA map.
To further verify TIA regulation of an alternative 59 splice site,
we constructed a reporter minigene containing the variable exon
33 and downstream intron and exon from CHD9 pre-mRNA
(Figure 6B). The only TIA crosslink cluster present in this region
located downstream of the intron-proximal 59 splice site
(Figure 5E). Overexpression of either TIA1 or TIAL1 significantly
increased inclusion of the variable portion of the exon, whereas
knockdown of the TIA proteins showed the opposite effect, which
could again be rescued by TIA overexpression (Figure 6B).
Replacing 40 nt of intronic sequence downstream of the intron-
proximal 59 splice site with a sequence from CDC25C pre-mRNA
rendered the minigene unresponsive to the changing TIA protein
levels (Figure 6B). This confirmed that the TIA crosslink clusters
identified the RNA sites that mediated the effect of TIA proteins at
the alternative 59 splice sites.
TIA Proteins Regulate the Usage of Alternative 39 Splice
Sites by Binding at 59 Splice Sites
The microarray also detected a splicing change in 84 alternative
39 splice sites, four of which were analysed by RT-PCR with a
75% (3/4) validation rate (Figure S9C, Table S4). The RNA map
of TIA binding showed no enrichment of TIA crosslink events at
the regulated alternative 39 splice sites (Figure 6C). Instead, there
was an increase in TIA crosslink event 10–28 nt downstream of
the preceding 59 splice site if TIA silenced inclusion of the variable
portion of the exon, as shown for C3orf23 pre-mRNA (Figures 6C
and S8B). Although the enrichment did not reach the significance
level, these observations indicated that TIA proteins might silence
the intron-proximal alternative 39 splice sites by binding at the
preceding 59 splice site.
In order to test this hypothesis, we constructed a reporter
minigene containing variable-length exon 4 and the upstream
intron and exon from C3orf23 pre-mRNA (Figure 6D). The only
TIA crosslink cluster present located downstream of the 59 splice
site (Figure S8B). Since the intron has a size of more than 6 kb, we
fused its first and last 600 nt to form the intron in the minigene.
Overexpression of TIA1 or TIAL1 protein significantly decreased
the inclusion of the variable part of the exon, whereas TIA
knockdown significantly increased the inclusion (Figure 6D). In
order to verify functionality of this binding site, the 83 nt
downstream of the 59 splice site were replaced with the
corresponding region from constitutive exon 2 of GAPDH pre-
mRNA (Figure 6D). This resulted in a loss of TIA regulation.
Surprisingly, the mutation abolished inclusion of the variable
portion of the exon, possibly due to the enhanced TIA-
independent recognition of the GAPDH 59 splice site. Taken
together, the minigene reporter analysis confirmed that TIA
binding downstream of the 59 splice site can affect the usage of
distal alternative 39 splice sites.
Discussion
The present study predicts the positive and negative effects of
TIA proteins on splicing of cassette and variable-length exons
based on experimental analysis of in vivo TIA-RNA interactions.
Consistent with previous observations, we found strong binding of
TIA1 and TIAL1 downstream of 59 splice sites where it exerts
local and distal effects on splicing regulation. In addition, binding
of both proteins was also enriched in ncRNAs and 39 UTR of
mRNAs. The latter is consistent with their role in translational
repression via binding AU-rich element (ARE) and with the role in
stress granules, where they promote the assembly of translation
pre-initiation complexes [18,19,39,40]. Further analyses of iCLIP
data could therefore provide novel insights into how TIA binding
mediates translational inhibition.
As shown in the example of the 39 UTR of MYC pre-mRNA,
TIA1 and TIAL1 crosslinking is quantitatively reproducible at the
level of individual nucleotides (Figure 2F). This allowed us to show
that TIA1 and TIAL1 have identical RNA binding specificity and
that both proteins bind to the same primary RNA sites. This result
is interesting from an evolutionary perspective, raising the question
of why two proteins with the same specificity have been
maintained in the genome. The redundancy between TIA1 and
TIAL1 might increase the robustness of gene expression.
Moreover, it is likely that the two proteins differ in their
interactions with other proteins and in their post-translational
modifications, allowing different signalling pathways to regulate
activity of the two proteins. Since the relative expression of TIA1
and TIAL1 varies among human tissues [16], this could allow
different signalling pathways to modulate expression of TIA-target
RNAs in different tissues.
The Positions of TIA-RNA Interactions Predict the Splicing
Effects of TIA1 and TIAL1
TIA crosslink clusters were identified downstream of 5% of
alternative and constitutive exons, suggesting that TIA proteins
play a widespread role in 59 splice site recognition. However, in
spite of this widespread TIA binding, we were able to use
consistent rules to predict the effects of TIA binding on splicing of
regulated alternative exons. Assessing TIA crosslinking at the 59
splice sites of both the alternative and the preceding exon enabled
us to distinguish between silenced and enhanced exons. Splice-
junction microarray analyses and minigene experiments validated
the accuracy of these predictions on a genome-wide scale and at
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the level of individual regulated exons, supporting the finding that
the position of TIA binding on pre-mRNA determines its dual
splicing effects.
The ability of iCLIP in predicting the dual TIA splicing effects is
particularly noteworthy in the case of variable-length exons, since
the distance between alternative splice sites is often very short, as
shown in the example of CLIP4 pre-mRNA (Figure 1C). The
ability of iCLIP to directly identify crosslink sites and thereby
resolve TIA binding at such proximal sites was crucial for the
accuracy in separating silenced from enhanced variable-length
exons.
TIA Effects on Variable-Length Exons Allow Evaluation of
the Different Models of Splicing Regulation
In the present study, we have evaluated both the local and distal
splicing effects of TIA binding at 59 splice sites. Locally, TIA
proteins can regulate alternative 59 splice sites in a manner
consistent with the splice site competition model [41]. TIA
proteins enhanced the closest upstream 59 splice site, leading to a
concomitant decrease in usage of the competing 59 splice site
(Figure 7A). Similarly, TIA binding downstream of a cassette exon
acts by promoting the usage of its 59 splice site (Figure 7B). A past
study evaluating splicing intermediates showed that in cases of
Nova binding downstream of enhanced exons, the downstream
intron is removed prior to the upstream one [4]. This result is
consistent with a splice site competition model, indicating that
Nova and TIA proteins can enhance cassette exons by promoting
the splicing pathway that uses the 59 splice site of the alternative
exon, with concomitant decrease in the exon skipping pathway
that uses the 59 splice site of the preceding exon (Figure 7B).
We also found that TIA binding can lead to distal splicing
silencing effects. This supports the hypothesis of indirect silencing
action, where an RNA-binding protein could cause a distal
negative splicing effect by its local enhancing function, initially
proposed to explain the same observation in the Nova RNA map
[4,25]. A recent study of PTB-RNA interactions observed an
opposite scenario where the local silencing function of PTB causes
a distal positive splicing effect [23]. These findings point to the
observation that a local splicing function of RNA-binding proteins
generally leads to reciprocal distal splicing effects. The study
analysing the distal effects of PTB proposed a model where
competition between the constitutive and the alternative 59 splice
site was responsible for these distal effects [23].
To gain further insights into the distal regulation of alternative
splicing, we analysed the effect of TIA binding on distal alternative
splice sites. Surprisingly, we found that TIA proteins regulate
usage of alternative 39 splice sites without binding directly at the 39
splice sites. This distal effect does not involve a competition
between the constitutive and the alternative 59 splice sites. Instead,
TIA proteins regulate the distal alternative 39 splice sites by
modulating recognition of the upstream 59 splice site (Figure 7C).
This result was also supported by the minigene experiment, which
showed that a constitutive non-TIA dependent 59 splice site
promotes skipping of the variable portion of the distal exon. This
suggests that regulation of a 59 splice site recognition can affect
splicing of downstream alternative 39 splice sites even if it doesn’t
compete with another 59 splice site. This effect could also
contribute to the splicing regulation of distal cassette exons
(Figure 7D).
Mechanistic Insights into the TIA-Dependent Regulation
of Alternative Splicing
Unlike Nova, FOX2, and PTB proteins [4,23,24,42], which
bind at positions close to either 39 or 59 splice sites, TIA RNA
maps did not identify significant binding at 39 splice sites or within
the alternative exons. Instead, TIA binding was enriched only
downstream of the exons, where TIA proteins were reported to
recruit U1 snRNP to the 59 splice sites [9–11]. It is clear that the
uridine-rich motifs downstream of exons are not the only
determinant of TIA binding, since these motifs are present also
in the polypyrimidine tracts upstream of exons. It is therefore
possible that TIA binds to RNA cooperatively in complex with U1
snRNP, which would ensure TIA binding only downstream of
exons.
Interestingly, TIA crosslinking was equally common down-
stream of constitutive and alternative exons. Past studies found
that uridine tracts are among the most enriched motifs
downstream of constitutive exons, but the function of TIA binding
to these motifs was not validated [15,43]. We found that TIA
binding downstream of constitutive exons often promotes efficient
splicing of the corresponding intron. Interestingly, this function is
shared with the yeast orthologue Nam8p, suggesting that it
represents a primary evolutionary function of the TIA proteins
[44–46].
We find that TIA proteins can cause a distal splicing effect by
regulating recognition of a constitutive 59 splice site, even if this
site does not compete with an alternative 59 splice site (Figure 7C).
Several models of splicing regulation could account for this effect.
TIA proteins might change the conformation of the U1 snRNP
complex in a way that promotes its pairing with the intron-distal 39
splice site. Alternatively, binding of TIA proteins could lead to a
change in the long-range RNA-RNA interactions, or a change in
interactions with other RNA-binding proteins that bind at a distal
site. Finally, the result could also be explained in light of the
splicing kinetics model. Kinetic parameters of splicing were shown
previously to influence the splice site choice [41]. By enhancing U1
snRNP recruitment to the 59 splice site, TIA proteins might allow
the splicing reaction to proceed faster, thereby shortening the time
available for definition of the downstream alternative exon. In
contrast, the slower splicing kinetics in knockdown cells could
allow additional time for trans-acting factors, such as SR proteins,
to recognise exonic elements that prevent skipping of the
alternative exon (Figure 7C, D) [47]. Such effects of splicing
kinetics might be related to the transcriptional effects on splicing,
which act partly by changing the ability of SR proteins to define
the alternative exons [48]. Taken together, this study of TIA
proteins highlights the importance of identifying the positions of
protein-RNA interactions with high precision in order to reveal
the full complexity of splicing regulation.
Figure 6. RNA maps of TIA-regulated variable-length exons. RNA maps showing the percentage of variable 59 splice site exons (A) or variable
39 splice site exons (C) with clustered TIA1/TIAL1 crosslink sites at exon/intron boundaries of variable exons and flanking constitutive exons, including
20 nt of exonic, 40 nt of variable exonic, and 60 nt of intronic sequence. The number of crosslink events at each region ‘‘x’’ 10–28 nt downstream of
exon/intron boundaries and the total number of exons analysed are shown for silenced (DIrank #1, blue bars), enhanced (DIrank $1, red bars), and
control variable exons (|DIrank|#0.1, black line). The positions with a significantly higher number of crosslinking events in TIA-regulated RNAs than in
control are indicated by red or blue dots above bars (* p,0.05, Fisher’s Exact Test). Minigene validation of variable 59 splice site exon in CHD9 pre-
mRNA (B) and variable 39 splice sites exon in C3orf23 pre-mRNA (D) are shown. Depiction and labelling is as described in the legend for Figure 4B.
doi:10.1371/journal.pbio.1000530.g006
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Methods
iCLIP and iCLAP Methods
HeLa cells were irradiated with UV light. Upon cell lysis, RNA
was partially fragmented using RNase I. For iCLIP, TIA1 or
TIAL1 were immunoprecipitated with protein G Dynabeads
(Invitrogen) conjugated to goat-anti TIA1 (Santa Cruz, C-20) or
goat-anti TIAL1 (Santa Cruz, C-18) antibody. For iCLAP, the
Strep/His-tagged proteins were affinity purified using Streptavidin
and Cobalt beads. RNA was ligated at 39 ends to an RNA adapter
and radioactively labelled on beads. After gel electrophoresis and
nitrocellulose membrane transfer, protein-RNA complexes were
visualised by autoradiogram. RNA was recovered by proteinase K
digestion and reverse transcribed using primers with adapter
regions separated by a BamHI restriction site and a barcode
region at their 59 end. cDNA was size-purified, circularised,
annealed to an oligonucleotide complementary to the restriction
site, and digested with BamHI. Linearised cDNA was then PCR-
amplified using primers complementary to the adapter regions and
subjected to high-throughput sequencing using Illumina GA2. A
more detailed description is available in Text S1.
Mapping Sequences to the Human Genome
The sequences corresponding to the individual experiment were
identified by their defined barcode, the random barcodes were
registered, and the barcodes were removed before mapping the
sequences to the human genome sequence (version Hg18/
NCBI36), allowing one mismatch using Bowtie version 0.10.1
(command line: -a -m 1 -v 1).
Randomisation of iCLIP Positions
The randomisation was done within co-transcribed regions that
were expected to have the same expression levels. For instance, a
single gene contains abundant exonic and non-abundant intronic
RNA, and intronic RNA contains non-coding RNA genes that are
usually highly abundant. We have randomised positions within
each individual intron, excluding the non-coding RNA genes.
Each non-coding RNA gene was randomised separately. Exons
were grouped into one single region for randomisation. However,
as evident in Figure 2B, the 39 UTR contains a higher cDNA
enrichment than the coding sequence; therefore, we randomised
positions in each UTR region separately from the coding
sequence. All annotations were based on the version Hg18/
NCBI36 of the human genome sequence. Each cDNA was
considered independent when randomising the positions.
Comparison of Crosslinking Nucleotide Positions
Only crosslink positions (but not the cDNA count) were
compared between the different datasets. Crosslink positions in
the first dataset define the position of 0 when analysing the
positions in the second dataset.
Analysis of Enriched Pentamers
For sequence analysis of iCLIP crosslink sites, the position of
the crosslinking site was extended 10 nt in both directions. The z
score for pentamer enrichment at the 21 nt region surrounding
the crosslink sites was then calculated relative to randomised
genomic positions. A more detailed description is available in
Text S1.
The splice-site competition model explains the local splicing effects of TIA binding.
The splicing kinetics model explains the distal splicing effects of TIA binding.
KD
KD
KD
ORA
C
B
D
Figure 7. An overview of the models of TIA-dependent splicing regulation. (A) TIA proteins can directly regulate 59 splice site competition
by enhancing either intron-proximal or intron-distal 59 splice sites. (B) TIA proteins directly regulate alternative cassette exon inclusion by enhancing
59 splice sites. (C) TIA proteins promote the use of intron-distal alternative 39 splice sites without directly modulating competition between the
alternative 39 splice sites. By enhancing 59 splice site recognition, TIA proteins decrease the inclusion of the variable portion of the exon. The splicing
kinetics model proposes that the splicing kinetics is affected by 59 splice site recognition, which then indirectly affects the ability of SR proteins and
other factors to define the variable portion of the distal exon. According to this model, the slower splicing kinetics in the absence of TIA increases the
time available to these factors to promote inclusion of the variable portion of the exon. (D) Similar to the effect on distal variable exons, a change in
splicing kinetics could contribute to the ability of TIA proteins to promote skipping of distal alternative cassette exon by binding at the upstream 59
splice site.
doi:10.1371/journal.pbio.1000530.g007
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Identification of Significant iCLIP Crosslink Sites
This followed the same statistical approach as the analysis of
CLIP sequence clusters [42] with a few modifications as described
in [28]. Rather than combining crosslink sites into larger clusters,
the crosslink sites within the clusters were kept individually in
order to preserve the nucleotide resolution of the data. A more
detailed description is available in Text S1.
siRNA Knockdown
Three different oligonucleotides were used together with a
scrambled control (Invitrogen, 12935-112). The following siRNA
oligonucleotides were used:
siTIA1-1: 59-GCAAGUUCCUGCAUAUGGAAUGUAU-39
siTIA1-2: 59-AGAAUAUCAGAUGCCCGAUGGUAA-39
siTIA1-3: 59-GGCAACAGGAAAGUCUAAGGGAUAU-39
siTIAL1-1: 59-CGGAUAUGGUUGGCAAGUUACCAA-39
siTIAL1-2: 59-CCGAACCAAUUGGGCCACUCGUAAA-39
siTIAL1-3: 59-GCGUCUGGGUUAACAGAUCAGCUUA-39
5 nM of each siRNA (siTIA1 and siTIAL1) were transfected
using Lipofectamine iMax (Invitrogen) according to manufactur-
er’s instructions. Cells were transfected again 2 d after the first
transfection and were harvested 2 d after the second transfection
for protein and RNA analyses.
Western Blot
The protein concentration was determined using Lowry’s Assay
(Bio-RAD). Goat anti-TIA1 antibody (1:1000) (Santa Cruz, C-20)
and anti-TIAL1 antibody (1:1000) (Santa Cruz, C-18) were used
to detect TIA1 and TIAL1 protein. Rabbit anti-GAPDH (1:5000)
(Cell signalling) was used for loading control. For overexpression,
mouse anti-Strep tag antibody (1:1000) (Qiagen) was used to detect
the tagged protein. Donkey anti-goat HRP, goat anti-rabbit HRP,
and goat anti-mouse HRP (Invitrogen) were used as secondary
antibodies. The membrane was visualised using ECL kit
(Amersham).
Splice-Junction Microarray
A total of six samples were used, three from the siRNA control
and three from KD3. The high-resolution splice-junction micro-
arrays were produced by Affymetrix, monitoring 260,488 exon-
exon junctions (each with eight probes) and 315,137 exons (each
with 10 probes). cDNA samples were prepared using the
GeneChip WT cDNA Synthesis and Amplification Kit (Affyme-
trix). Analysis of microarray data was done using version 3 of
ASPIRE (Analysis of SPlicing Isoform Reciprocity). ASPIRE
predicts splicing changes from reciprocal sets of microarray probes
that recognise either inclusion or skipping of an alternative exon.
In version 3 the background detection levels are experimentally
determined for each probe, allowing background subtraction in a
probe-specific manner [28]. Description of RT-PCR validation is
available in Text S1.
iCLIP RNA Maps
RNA maps were produced by assessing the positioning of
clustered crosslink sites at the exon/intron boundaries of
alternative and flanking exons. For each exon, the positions
between 20 nt of exonic and 60 nt of intronic sequence for each of
the splice sites were analysed. When introns or exons were shorter
than two times the length of the analysed area, analysis was
restricted to region up the middle of the intron and exon. To draw
the RNA map, the percentage of exons containing a crosslink site
at the corresponding position is drawn.
Minigene Construction and Transfection
The alternative exons with the flanking constitutive exons were
amplified by PCR with genomic DNA from HeLa cells and cloned
into pcDNA3 vectors. The 40 nt downstream of the exon-intron
boundaries where TIA binding site are present were mutated to
sequences with no observed TIA binding sites. In the case of the
enhanced cassette exon (OGT1) and the alternative 59 splice sites
(CHD9), the 40 nt were replaced with sequences downstream of a
silenced cassette exon (CDC25C). In the case of the alternative 39
splice sites (C3orf23), the 83 nt were replaced with sequences
downstream of GAPDH exon 2. The intron of C3orf23 was too
long, so only 600 nt from the exon-intron boundaries on either
side were cloned. The constructs were transfected together with
GFP, TIA1, or TIAL1-pcDNA3/Step-His vectors using polyfect
(Qiagen). The siRNA for TIA1 (KD3) and negative control were
transfected at the same time using Lipofectamine iMax (Invitro-
gen). The cells were collected 2 d later and the splicing effects were
assessed by RT-PCR using a T7 forward primer (59-TAATAC-
GACTCACTATAGGG-39) and gene-specific reverse primers
(Table S4).
Supporting Information
Figure S1 iCLIP and iCLAP of TIA1 and TIAL1. (A)
Western blot for TIA1 and TIAL1 in HeLa, TIA1 or TIAL1
overexpressed, and TIA1/TIAL1 double KD cells. GAPDH was
used as loading control. (B) Western blot with either antibody
upon immunoprecipitation using the same antibody. Protein G
beads were used for immunoprecipitation. The strong signal at
6130 kDa represents immunoglobulin cross-reactivity. A weak
signal for native TIA1 and TIAL1 is seen at 650 kDa, and the
overexpressed proteins migrate at only slightly higher molecular
weight. (C) Autoradiogram of 32P-c-ATP labelled RNA in
complex with TIA1 or TIAL1 in iCLIP. The low RNase I results
in a shift of the complex. (D) The final PCR gel for each protein
before being submitted to sequencing on the Illumina GA2 system.
(E) iCLAP purification of overexpressed TIA1 and TIAL1 with
Strep and His tag. The proteins were first purified using Strep
beads and then purified with Cobalt beads. (F) iCLAP autoradio-
gram for TIA1 and TIAL1. Vector-transfected cells and no UV-
crosslinking samples were used as controls.
Found at: doi:10.1371/journal.pbio.1000530.s001 (1.51 MB PDF)
Figure S2 A global view of replicate iCLIP and iCLAP
experiments for TIA1 and TIAL1. The three individual
replicates of iCLIP for TIA1 or TIAL1 together with iCLAP for
either protein are shown in BedGraph format in the UCSC hg18
Genome Browser. cDNA counts at crosslink sites on the sense
(purple) or anti-sense strand (orange) of the chromosome 20 are
shown. The cDNA counts are shown on the left of the BedGraphs.
Found at: doi:10.1371/journal.pbio.1000530.s002 (0.27 MB PDF)
Figure S3 Reproducibility of replicate iCLIP and iCLAP
experiments for TIA1 and TIAL1. (A) Fold-enrichment of
pentamers in the 21 nt sequence surrounding crosslink sites
(210 nt to +10 nt) are shown for TIA1 and TIAL1 iCLIP. (B)
Pentamer z scores at the 21 nt sequence surrounding crosslink sites
(210 nt to +10 nt) are shown for TIA1 and TIAL1 iCLAP. The
sequences for the two most enriched pentamers and the Pearson
correlation coefficient (r) are shown. (C,D) Reproducibility of
sequence composition at crosslink nucleotides. Frequencies of
pentanucleotides overlapping with crosslink nucleotides are shown
for the three replicate experiments for TIA1 (C) or TIAL1 (D). (E)
Weblogo showing base frequencies of crosslink nucleotides and
20 nt of surrounding genomic sequence. Positions 0 and 1
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correspond to crosslink nucleotide and first position of cDNA
sequence, respectively. (F) Reproducibility analysis comparing the
positions of clustered crosslink sites of TIA1 and TIAL1. Black
bars show the number of crosslink nucleotides from TIA1 iCLIP
that are reproduced in TIAL1 iCLIP with a given offset. An offset
of 0 nt indicates the number of crosslink nucleotides from TIA1
iCLIP that were reproduced by a crosslink nucleotide at exactly
the same position in TIAL1 iCLIP. Negative or positive offset
values indicate whether the reproducing TIAL1 crosslink position
is located upstream or downstream of the TIA1 crosslink
nucleotide, respectively. The orange curve depicts results of the
same analysis upon randomisation of TIA1 crosslink nucleotide
positions. (G–I) Contour plots comparing TIA1 and TIAL1 cDNA
enrichment in ncRNAs (G), 39 UTRs (H), and introns (I). The
cDNA enrichment was calculated by dividing the density in each
RNA region by the whole-genome cDNA density. The legend
shows the minimal density of RNAs in an area of the plot
corresponding to the colour of each contour.
Found at: doi:10.1371/journal.pbio.1000530.s003 (0.59 MB
PDF)
Figure S4 TIA1 and TIAL1 crosslink to different parts of
chromosomes. (A) Global view of chromosome 6 with TIA1
and TIAL1 iCLIP crosslink sites. The chromosome is shown at the
top. The genes are shown below the tracks. The zoom-in view
shows the MAPK14 gene. This gene has two mutually exclusive
exons, and splicing change was detected by the microarray. The
regions with enriched iCLIP cDNAs were zoomed in further down
to nucleotide resolution. (B) Global view of the same chromosome.
This time, the region with very high numbers of cDNAs was
zoomed in. The crosslink sites map to the antisense strand, and
three major peaks were further zoomed in. The first one maps to
the 39 UTR of a histone gene (1), whereas the other two map to
non-coding tRNAs (2, 3).
Found at: doi:10.1371/journal.pbio.1000530.s004 (0.71 MB
PDF)
Figure S5 The location of TIA1 and TIAL1 crosslink
sites in previously described pre-mRNAs. (A) TIA1 and
TIAL1 crosslink sites in FAS pre-mRNA. In the mid panel, exons
5, 6, and 7 are shown, with exon 6 being alternatively spliced. The
arrows above the bar graphs show the previously identified TIA
binding sites. (B) TIA1 and TIAL1 crosslink sites in MYC pre-
mRNA. Most of the sites were concentrated at the 39 UTR. Upper
and lower panels depict enlarged regions showing nucleotide
resolution of iCLIP crosslink sites.
Found at: doi:10.1371/journal.pbio.1000530.s005 (0.29 MB PDF)
Figure S6 TIA1/TIAL1 siRNA knock-down in HeLa
cells. Western blot for TIA1/TIAL1 KD samples. Either TIA1
or TIAL1 was detected in the upper panels and GAPDH in the
bottom panel as loading control.
Found at: doi:10.1371/journal.pbio.1000530.s006 (0.19 MB
PDF)
Figure S7 TIA1/TIAL1 regulate intron retention. (A)
iCLIP crosslink sites in the silenced intron in PPIA pre-mRNA.
The exon is shown by the rectangle, and the alternative intron by
the arrowed line. The area surrounding the 59 splice site is shown
at a greater resolution below. (B) 18 intron retention events
detected by the microarray were analysed by real-time PCR in
control and TIA1/TIAL1 KD samples (prepared using the third
siRNA oligonucleotide).
Found at: doi:10.1371/journal.pbio.1000530.s007 (0.33 MB
PDF)
Figure S8 TIA binding causes distal splicing effects. (A)
UCSC hg18 Genome Browser views of iCLIP crosslink sites
around the two mutually exclusive exons of FYN pre-mRNA. The
areas surrounding both 59 splice sites are shown at a higher
resolution. Capillary electrophoresis of RT-PCR from KD
samples and its quantification are shown below. (B) UCSC
Genome Browser views of the alternative 39 splice site in C3orf23
pre-mRNA. The areas surrounding the 59 splice site of the
preceding exon and the alternative 39 splice sites are shown at a
higher resolution. Capillary electrophoresis of RT-PCR from KD
samples and its quantification are shown below (* p,0.05,
*** p,0.001, one-way ANOVA).
Found at: doi:10.1371/journal.pbio.1000530.s008 (0.43 MB PDF)
Figure S9 RT-PCR validation of splicing events detected
by the microarray using QIAxcel. (A) Cassette exons events
validated by QIAxcel and their quantification are shown next to
the pictures. (B) Validated alternative 59 splice sites regulated by
the TIA proteins. (C) Validated alternative 39 splice sites regulated
by the TIA proteins. (D) Validated alternative 59 splice sites
predicted by iCLIP. * p,0.05, ** p,0.01, *** p,0.001, one-way
ANOVA. (A–D) Depiction and labelling as in Figure 3D–E. (E)
The percentage of change in exon inclusion (DI) detected by
microarray and RT-PCR are plotted against each other.
Found at: doi:10.1371/journal.pbio.1000530.s009 (1.10 MB PDF)
Table S1 Information used to map the sequencing
results to genome.
Found at: doi:10.1371/journal.pbio.1000530.s010 (0.04 MB PDF)
Table S2 Mapping information for iCLIP and iCLAP
data.
Found at: doi:10.1371/journal.pbio.1000530.s011 (0.03 MB PDF)
Table S3 Enrichment of pentamers surrounding TIA1 and
TIAL1 iCLIP and iCLAP crosslink sites.
Found at: doi:10.1371/journal.pbio.1000530.s012 (0.02 MB PDF)
Table S4 RT-PCR primers for validation of splicing
event predicted by the microarray.
Found at: doi:10.1371/journal.pbio.1000530.s013 (0.08 MB PDF)
Table S5 qPCR primers for validation of intron reten-
tion event.
Found at: doi:10.1371/journal.pbio.1000530.s014 (0.06 MB PDF)
Text S1 Supplementary methods. A detailed explanation of
the iCLIP, iCLAP, z score analysis, identification of significant
iCLIP crosslink sites, and RT-PCR analysis is provided.
Found at: doi:10.1371/journal.pbio.1000530.s015 (0.04 MB
DOC)
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